Skip to main content
. 2024 Dec 9;11:1405606. doi: 10.3389/fcvm.2024.1405606

Table 2.

Comparison of clinical characteristics between PTS group and PTA group before treatment.

PTS group PTA group p-value
Number of patients 17 (65.38) 9 (34.62)
Age, years 57.31 ± 2.93 54.57 ± 6.14 0.992
Male 7 (41.18) 7 (77.78) 0.081
Age of starting dialysis, years 51.92 ± 2.94 48.42 ± 6.69 0.978
Duration of HD, years 7.00 (2.00–9.00) 4.00 (2.00–13.00) 0.957
Stenosis degree, % 100.00 (95.00–100.00) 84.28 ± 6.40 0.001
Length of lesion, mm 30.77 ± 3.62 22.86 ± 5.10 0.199
Previous catheter retention time, months 12.00 (6.00–24.00) 6.00 (6.00–15.00) 0.558
Weight, Kg 55.35 ± 2.13 55.35 ± 2.31 0.809
SBP, mmHg 142.54 ± 7,51 136.71 ± 5.07 0.526
DBP, mmHg 86.15 ± 6.06 77.00 ± 2.60 0.159
MAP, mmHg 104.95 ± 6.36 96.91 ± 2.55 0.211
Pulse pressure, mmHg 56.38 ± 3.49 59.71 ± 5.45 0.872
HGB, g/L 105.15 ± 5.29 107.71 ± 6.16 0.424
WBC, 10^9/L 6.31 ± 0.55 6.86 ± 1.21 0.418
PLT, 10^9/L 229.00 ± 24.79 186.86 ± 18.74 0.377
BUN, mmol/L 20.73 ± 1.27 20.90 ± 3.31 0.632
Cr, μmol/L 909.08 ± 73.33 783.69 ± 48.11 0.4
Ca, mmol/L 2.48 ± 0.08 2.39 ± 0.06 0.724
P, mmol/L 2.09 ± 0.15 2.23 ± 0.36 0.367
iPTH, pg/ml 485.66 ± 116.82 272.00 ± 96.43 0.284
LDH, U/L 210.46 ± 17.52 229.57 ± 18.46 0.588
ALB, g/L 40.20 ± 0.87 40.04 ± 2.04 0.846
UA, μmol/L 403.91 ± 33.50 338.00 ± 72.79 0.35
LDL-C, mmol/L 2.35 ± 0.19 2.41 ± 0.28 0.857
INR 1.02 ± 0.02 1.10 ± 0.03 0.016
FIB, g/L 3.99 ± 0.31 3.70 ± 0.29 0.537
D-Dimer, ng/ml 1,077.69 ± 208.78 1,084.29 ± 266.75 0.476
ALP, U/L 109.00 (72.50–139.00) 73.00 (64.00–90.00) 0.08
CRP, g/L 4.31 (1.28–10.38) 9.11 (3.08–16.03) 0.865
CK, U/L 76.00 (64.50–120.00) 110.00 (65.00–210.00) 0.62